Trial NCT03935555

View at ClinicalTrials.gov 
Org. Study IDs: PU-H71-01-003

Last trial update was posted on 2022-11-17

MeSH Interventions

9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-

MeSH Conditions

Polycythemia Polycythemia Vera Primary Myelofibrosis Thrombocythemia, Essential Thrombocytosis

Other Conditions

Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF) Post-Polycythemia Vera Myelofibrosis (Post-PV MF) Primary Myelofibrosis (PMF)

Stopping Reasons

Samus Therapeutics company closure

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID